Smart Money Alert

Windlas Biotech Limited

IncreasedQuarterly

WINDLASPharmaceuticalsMarket Cap₹2K Cr

Stake

1.11% → 1.43%

Bandhan Mutual Fund

Mutual Fund

The move

Bandhan Mutual Fund increased its stake in Windlas Biotech Limited from 1.11% to 1.43% by buying 61,858 shares. The stake is worth ₹25.13 Cr based on the company's share price of ₹852.25.

About Windlas Biotech Limited

Visit stock

A leading pharmaceutical contract development and manufacturing organization, Windlas Biotech specializes in producing solid and liquid dosage forms for domestic and international clients. The company provides comprehensive CDMO services including product discovery, development, and commercial manufacturing of generic and complex generic medications. Its vertically integrated operations, technical capabilities, and focus on quality manufacturing distinguish it within India's pharmaceutical sector.

About Bandhan Mutual Fund

Visit investor

Formerly IDFC Mutual Fund, rebranded after Bandhan Financial Holdings acquired IDFC's AMC in 2023. Manages over Rs 1.5 lakh crore. Known for strong debt and liquid funds, plus well-regarded equity offerings including the IDFC-lineage Sterling Value Fund and Focused Equity Fund. One of the cleaner transitions in Indian AMC ownership history.

Get the next move the moment it happens.

Follow Bandhan Mutual Fund and Windlas Biotech Limited on WhaleWatch, alongside 300+ top investors, funds and FPIs. The newest moves are waiting for you inside.

Explore

Windlas Biotech Limited shareholders Bandhan Mutual Fund's portfolio All investors All stocks

🤖 We track their every move, post, interview and article. Obsessively.

⚡ Every move reaches your feed in minutes, while it still carries an edge

📊 Stake changes, bulk deals and insider trades, all tracked in one place

📰 A two-minute morning brief, so you start the day already ahead

More moves in Windlas Biotech Limited

ICICI Prudential Mutual FundDecreased

ICICI Prudential Mutual Fund decreased its stake in Windlas Biotech Limited from 5.19% to 3.42%, selling 3,89,179 shares. The value of the sold shares is approximately ₹33.17 Cr at ₹852.25 apiece.

16 Jul 2026

ICICI Prudential Mutual FundDecreased

ICICI Prudential Mutual Fund sold 5,40,642 shares of Windlas Biotech for ₹43.12 crore at ₹797.55 apiece, decreasing its stake from 6.96% to 4.33% and crossing the 5% disclosure threshold.